Lagis Enterprise (6730) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 常廣

Lagis Enterprise (6730) reported revenue of NT$41.2 million for Oct 2026, -3.3% year on year and -6.0% from the previous month. Revenue for Jan–Oct 2026 was NT$416 million (+2.4% year on year).

In Oct 2026, it ranked No. 107 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$35.7 million24/10Nov 2024 NT$39 millionDec 2024 NT$31.9 millionJan 2025 NT$40.7 millionFeb 2025 NT$33.4 million25/02Mar 2025 NT$41.6 millionApr 2025 NT$41.3 millionMay 2025 NT$39.2 millionJun 2025 NT$41.1 million25/06Jul 2025 NT$43.6 millionAug 2025 NT$42 millionSep 2025 NT$40.8 millionOct 2025 NT$42.6 million25/10Nov 2025 NT$37.4 millionDec 2025 NT$44 millionJan 2026 NT$42.7 millionFeb 2026 NT$34.3 million26/02Mar 2026 NT$37.5 millionApr 2026 NT$39.2 millionMay 2026 NT$41.8 millionJun 2026 NT$46.5 million26/06Jul 2026 NT$45.4 millionAug 2026 NT$43.5 millionSep 2026 NT$43.8 millionOct 2026 NT$41.2 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$41.2 million-3.3%-6.0%
Sep 2026NT$43.8 million+7.3%+0.6%
Aug 2026NT$43.5 million+3.6%-4.1%
Jul 2026NT$45.4 million+4.2%-2.3%
Jun 2026NT$46.5 million+13.3%+11.3%
May 2026NT$41.8 million+6.5%+6.6%
Apr 2026NT$39.2 million-5.2%+4.4%
Mar 2026NT$37.5 million-9.7%+9.5%
Feb 2026NT$34.3 million+2.6%-19.7%
Jan 2026NT$42.7 million+4.9%-2.9%
Dec 2025NT$44 million+38.0%+17.7%
Nov 2025NT$37.4 million-4.1%-12.2%
Oct 2025NT$42.6 million+19.1%+4.3%
Sep 2025NT$40.8 million+9.2%-2.9%
Aug 2025NT$42 million+15.2%-3.6%
Jul 2025NT$43.6 million-1.7%+6.1%
Jun 2025NT$41.1 million+0.0%+4.7%
May 2025NT$39.2 million+1.0%-5.1%
Apr 2025NT$41.3 million+13.9%-0.6%
Mar 2025NT$41.6 million+5.5%+24.3%
Feb 2025NT$33.4 million-2.6%-18.0%
Jan 2025NT$40.7 million+2.5%+27.7%
Dec 2024NT$31.9 million-27.9%-18.2%
Nov 2024NT$39 million-4.2%+9.1%
Oct 2024NT$35.7 million-8.4%-4.4%

Jan–Oct 2026 cumulative: NT$416 million (+2.4% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Lagis Enterprise vs PEC / Lagis Enterprise vs Lotus Pharm / Lagis Enterprise vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16